Tristel Gets FDA Approval for Ultrasound Disinfectant
05 Giugno 2023 - 9:19AM
Dow Jones News
By Elena Vardon
Tristel on Monday said its ULT high-level disinfectant has
gotten approval by the U.S. Food and Drug Administration for its
immediate sale for use on endocavity ultrasound probes and skin
surface transducers.
The manufacturer of infection-prevention products said it will
launch the product in the U.S. market in October. The group is
working with Parker Laboratories and established a manufacturing
base in New Jersey to make the disinfectant, which it will
distribute using Parker's network for the ultrasound market.
Its DUO intermediate level disinfectant is now registered in all
U.S. states, the London-listed group added.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
June 05, 2023 03:04 ET (07:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni Tristel (LSE:TSTL)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Tristel (LSE:TSTL)
Storico
Da Mag 2023 a Mag 2024